Starbucks launches Trio Macchiato this spring

Starbucks’ Trio Macchiato includes a new Maple Macchiato, Date Macchiato and Caramel Macchiato.
Updated 17 March 2017
0

Starbucks launches Trio Macchiato this spring

Marking the start of the spring season, Starbucks has launched its Trio Macchiato: a new Maple Macchiato, Date Macchiato and Caramel Macchiato, a combination that brings coffee lovers a choice of espresso and their favorite Starbucks beverages.
The Maple Macchiato is a new beverage ideal for those who love rich and sweet flavors. Customers will relish the strong vanilla notes with a maple syrup drizzle, finished with foam and milk.
Date Macchiato is a new addition to Starbucks, combining freshly steamed milk with vanilla flavored syrup marked with espresso, and topped with date drizzle.
Caramel Macchiato, a trademark for Starbucks, is one of the most favorite beverages, created with fresh steamed milk, vanilla flavor, and a perfect dose of Starbucks espresso with velvety texture and caramel finish.
“Offering a choice of three Macchiatos stems from our commitment to bringing our customers new and exciting beverages. The different taste profiles allow our customers the choice to discover their new passion. We are also offering the same beverages in an iced version so they can enjoy the beverage at different times of the day,” said Rana Shaheen, regional communications and CSR manager — MENA, Starbucks.
Starbucks is also introducing its “3 Region Blend” coffee. This blend combines the finest beans from each of the world’s three coffee-growing regions — Latin America, Africa/Arabia and Asia/Pacific. With floral, citrus and herbal notes, this medium-bodied blend is the perfect new addition to your latte.


Robotic-assisted surgery at JHAH a first for Kingdom

Updated 23 June 2019
0

Robotic-assisted surgery at JHAH a first for Kingdom

Johns Hopkins Aramco Healthcare (JHAH) has become the first hospital in Saudi Arabia to perform a robotic-assisted hysterectomy using fluorescent dye.

“The precision achieved through the use of robotic-assisted surgery has multiple benefits for patients,” said Dr. Turky Al-Rujaib, JHAH gynecologic oncologist, who along with Dr. Fahad Al-Mulhim, gynecologist, performed the procedure for endometrial cancer. “Women whose hysterectomies are robotic-assisted surgeries have less pain and blood loss, shorter hospital stays, require fewer narcotics and recover more quickly.”

JHAH’s robotic surgery program began in December 2016 when Dr. Tareq M. Al-Tartir, JHAH sub-specialist surgeon, and his team collaborated with Dr. Mohamad Allaf, professor of urology, oncology and biomedical engineering at Johns Hopkins School of Medicine (JHSoM) and director of minimally invasive urology, and his team. They jointly conducted the first surgeries in the Kingdom using the da Vinci Xi robotic surgical system. The program has since expanded and includes gynecological surgeries and bariatric surgery.

“This successful operation could not have been done without the support of the JHAH robotic team,” said Dr. Al-Mulhim. “We are pleased to report the patient is recovering well. This is a tremendous achievement that going forward will improve the outcomes for many of our patients here at JHAH.”

The robot’s “hands” have a high degree of dexterity, allowing surgeons the ability to operate in very tight spaces, for example the pelvis, that would otherwise only be accessible through open surgery with long incisions. Life after surgery is improved with this technique as there is minimal scarring, fewer postoperative complications and often a faster return to normal activities. 

JHAH is the result of a joint venture between Saudi Aramco, a world leader in energy, and Johns Hopkins Medicine, one of the world’s leading academic health systems. This health care organization is designed to drive and enhance the well-being of the community in an environment of growth and learning, by providing innovative, integrated and patient-centered care to Saudi Aramco’s employees and health care beneficiaries.